These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29589834)

  • 1. Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias.
    Tadmor T; Levy I; Vadasz Z
    Turk J Haematol; 2018 May; 35(2):116-121. PubMed ID: 29589834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies.
    Palumbo GA; Parrinello NL; Giallongo C; D'Amico E; Zanghì A; Puglisi F; Conticello C; Chiarenza A; Tibullo D; Raimondo FD; Romano A
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
    Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
    Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d is a novel cell-surface marker for human monocytic myeloid-derived suppressor cells with T cell suppression activity in peripheral blood after allogeneic hematopoietic stem cell transplantation.
    An B; Lim JY; Jeong S; Shin DM; Choi EY; Min CK; Hong SH
    Biochem Biophys Res Commun; 2018 Jan; 495(1):519-525. PubMed ID: 29108995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.
    Casacuberta-Serra S; Parés M; Golbano A; Coves E; Espejo C; Barquinero J
    Immunol Cell Biol; 2017 Jul; 95(6):538-548. PubMed ID: 28108746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
    Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
    Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
    Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
    Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody.
    Dominguez GA; Condamine T; Mony S; Hashimoto A; Wang F; Liu Q; Forero A; Bendell J; Witt R; Hockstein N; Kumar P; Gabrilovich DI
    Clin Cancer Res; 2017 Jun; 23(12):2942-2950. PubMed ID: 27965309
    [No Abstract]   [Full Text] [Related]  

  • 15. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
    Fortin C; Yang Y; Huang X
    Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
    Wegner A; Verhagen J; Wraith DC
    Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.